Skip to main content
. Author manuscript; available in PMC: 2015 Jan 19.
Published in final edited form as: J Nerv Ment Dis. 2014 Jul;202(7):530–538. doi: 10.1097/NMD.0000000000000154

Table 3.

Respondent’s Knowledge and Attitudes about Genetic Tests

Total Gender Binary Logistic (Controlling for Age)

% (N) Male Female AOR a p value b CI c

Total 100% (372)

To best of your understanding, is there a GT available for:
Alzheimer’s
Yes d 61.7% (171) 60.0% (96) 65.7% (65)
No 38.3% (106) 40.0% (64) 34.3% (34)

Autism
Yes 19.6% (54) 18.1% (29) 21.2% (21)
No e 80.4% (221) 81.9% (131) 78.8% (78)

Borderline Personality Disorder 0.14 0.068 0.02–1.16
Yes 4.0% (11) 6.3% (10) 1.0% (1)
No f 96.0% (264) 93.7% (149) 99.0% (98)

Intelligence
Yes 7.6% (21) 8.8% (14) 7.1% (7)
Nof 92.4% (254) 91.2% (145) 92.9% (92)

Major Depression
Yes 19.6% (54) 18.2% (29) 22.0% (22)
Nof 80.4% (222) 81.8% (130) 78.0% (78)

Obsessive Compulsive Disorder
Yes 9.9% (27) 11.4% (18) 8.1% (8)
Nof 90.1% (247) 88.6% (140) 91.9% (91)

Schizophrenia 0.61 0.088 0.34–1.07
Yes 25.0% (65) 21.2% (34) 31.0% (31)
No g 75.0% (195) 78.8% (126) 69.0% (69)

Social Anxiety Disorder 0.13 0.049 0.02–0.99
Yes 4.7% (13) 7.5% (12) 1.0% (1)
Nof 95.3% (261) 92.5% (147) 99.0% (97)

Suicidality
Yes 6.6% (18) 8.2% (13) 4.1% (4)
Nof 93.4% (255) 91.8% (145) 95.9% (94)

In the future, will GT have a role in diagnosing:
Alzheimer’s
Yes 94.2% (243) 94.3% (150) 93.9% (93)
No 5.8%(15) 5.7% (9) 6.1% (6)

Autism
Yes 83.7% (216) 83.0% (132) 84.8% (84)
No 16.3% (42) 17.0% (27) 15.2% (15)

Bipolar Disorder 0.56 0.06 0.30–1.02
Yes 79.2% (205) 83% (132) 73% (73)
No 20.8% (54) 17% (27) 27% (27)

Major Depression 0.63 0.094 0.37–1.08
Yes 68.3% (177) 72.3% (115) 62% (62)
No 31.7% (82) 27.7% (44) 38% (38)

Schizophrenia 0.49 0.03 0.26–0.93
Yes 81.2% (211) 85% (136) 75% (75)
No 18.8% (49) 15% (24) 25% (25)
a

Adjusted Odds Ratio

b

P value shown if <0.1

c

Confidence Interval

d

A genetic test exists and is used clinically, though not widely.

e

At time of survey, recent studies had indicated a viable test had been developed. This has since been refuted.

f

No clinically useful genetic test exists.

g

Genetic markers have been identified for a subset of patients, though a clinically useful test does not exist.